We have an established track record of excellence in R&D. Our commitment to innovation and continuous improvement has enabled us to remain at the forefront of pharmaceutical advancements in the CDMO sector. Our R&D teams are dedicated to developing differentiated dosages, enhancing manufacturing processes, and exploring novel therapeutic areas. Our R&D initiatives are aimed at innovation in relation to taste and odour masking, targeted drug release, solubility/dissolution enhancement, reduced excipient burden, permeation enhancement, and stability enhancement, among others. Our focus on R&D has resulted in the development of 220+ innovative formulations since the commencement of our operations.